[Other] Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA |
Reward10points
|
20
Springer : Lipid Metabolism in Insect Vectors of Diseases
100
Microgrid
20
[Single chapter]Molecular Diagnosis
20
Clinical Evaluation of Low-shrinkage Bioactive Material Giomer Versus Nanohybrid Resin Composite Restorations: A Two-year Prospective Controlled Clinical Trial
20
Allograft Reconstruction for Extensor Mechanism Rupture After Total Knee Arthroplasty: 4.8-Year Follow-Up
